Last reviewed · How we verify
placebo to match tiotropium — Competitive Intelligence Brief
marketed
Respiratory
Small molecule
Live · refreshed every 30 min
Target snapshot
placebo to match tiotropium (placebo to match tiotropium) — GlaxoSmithKline. This is an inert placebo formulation designed to match the physical and sensory characteristics of tiotropium inhalation powder for use in blinded clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| placebo to match tiotropium TARGET | placebo to match tiotropium | GlaxoSmithKline | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- placebo to match tiotropium CI watch — RSS
- placebo to match tiotropium CI watch — Atom
- placebo to match tiotropium CI watch — JSON
- placebo to match tiotropium alone — RSS
Cite this brief
Drug Landscape (2026). placebo to match tiotropium — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-to-match-tiotropium. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab